{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:12:22Z","timestamp":1782918742093,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/40\/NCD-III"],"award-info":[{"award-number":["5\/13\/40\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bbagen.2023.130317","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T02:22:22Z","timestamp":1675131742000},"page":"130317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyaluronate decorated polyethylene glycol linked poly(lactide-co-glycolide) nanoparticles encapsulating MUC-1 peptide augmented mucosal immune response in Balb\/c mice through inhalation route"],"prefix":"10.1016","volume":"1867","author":[{"given":"Kiran","family":"Jyoti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjoo","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2023.130317_bb0005","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.12688\/f1000research.11471.1","article-title":"Recent advances in the management of non-small cell lung cancer","volume":"6","author":"Shojaee","year":"2017","journal-title":"F1000Res."},{"issue":"1","key":"10.1016\/j.bbagen.2023.130317_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbagen.2023.130317_bb0015","series-title":"Cancer Facts & Figures","author":"American Cancer Society","year":"2019"},{"key":"10.1016\/j.bbagen.2023.130317_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1586\/erv.13.14","article-title":"Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer","volume":"12","author":"Limacher","year":"2013","journal-title":"Expert Rev. Vaccines"},{"issue":"18","key":"10.1016\/j.bbagen.2023.130317_bb0025","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1080\/14656566.2018.1540591","article-title":"Afatinib and Erlotinib in the treatment of squamous-cell lung cancer","volume":"19","author":"Tagliamento","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.bbagen.2023.130317_bb0030","author":"Roswell Park Cancer Institute"},{"key":"10.1016\/j.bbagen.2023.130317_bb0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/21645515.2017.1373921","article-title":"Rittner, K, sequential administration of MVA-based vaccines and PD-1\/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: preclinical studies with MVA-\u03b2Gal and MVA-MUC1 (TG4010) in a murine tumor model","volume":"14","author":"Remy-Ziller","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.bbagen.2023.130317_bb0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/B978-0-12-407190-2.00007-1","article-title":"Y, therapeutic cancer vaccines: past, present, and future","volume":"119","author":"Guo","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbagen.2023.130317_bb0045","first-page":"37","article-title":"BLP-25 liposomal vaccine: a promising potential therapy in non-small-cell lung cancer, expert rev","volume":"2","author":"Powell","year":"2008","journal-title":"Respir. Med."},{"key":"10.1016\/j.bbagen.2023.130317_bb0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1517\/14712598.2011.598146","article-title":"Dubinett, S, MUC1 peptide vaccine mediated antitumor activity in non-small cell lung cancer","volume":"11","author":"Sharma","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"5","key":"10.1016\/j.bbagen.2023.130317_bb0055","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PPO.0b013e318233e6b4","volume":"17","author":"Kelly","year":"2011","journal-title":"Cancer J. (Sudbury, Mass.)"},{"issue":"1","key":"10.1016\/j.bbagen.2023.130317_bb0060","first-page":"59","article-title":"Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. The lancet","volume":"15","author":"Butts","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.bbagen.2023.130317_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3816\/CLC.2001.n.018","article-title":"Longenecker, M, phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB\/IV non-small-cell lung cancer","volume":"3","author":"Palmer","year":"2001","journal-title":"Clin. Lung Cancer"},{"issue":"5","key":"10.1016\/j.bbagen.2023.130317_bb0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/17425247.2011.565326","article-title":"Opportunities and challenges of the pulmonary route for vaccination","volume":"8","author":"Blank","year":"2011","journal-title":"Expert Opin. Drug Del."},{"issue":"15 Pt 2","key":"10.1016\/j.bbagen.2023.130317_bb0075","first-page":"s4652","article-title":"L-BLP25: a peptide vaccine strategy in non small cell lung cancer. Clinical cancer research\u202f: an official journal of the American association for","volume":"13","author":"Sangha","year":"2007","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbagen.2023.130317_bb0080","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood.V90.9.3245","article-title":"N, dendritic cells: unique leukocyte populations which control the primary immune response","volume":"90","author":"Hart","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbagen.2023.130317_bb0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/stem.150409","article-title":"Dendritic cell development: multiple pathways to nature\u2019s adjuvants","volume":"15","author":"Shortman","year":"1997","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.bbagen.2023.130317_bb0090","doi-asserted-by":"crossref","unstructured":"S. Arpicco, G. De Rosa, E. Fattal, Lipid-based Nanovectors for targeting of CD44-overexpressing tumor cells, J. Drug Del. 2013; 2013: Article ID 860780.","DOI":"10.1155\/2013\/860780"},{"issue":"12","key":"10.1016\/j.bbagen.2023.130317_bb0095","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1034\/j.1398-9995.1999.00277.x","article-title":"Overexpression of CD44 on alveolar eosinophils with high concentrations of soluble CD44 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia","volume":"54","author":"Katoh","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.bbagen.2023.130317_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bbagen.2023.130317_bb0105","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1074\/jbc.R100036200","article-title":"D, Hyaluronan-binding proteins: tying up the giant","volume":"277","author":"Day","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2023.130317_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.colsurfb.2011.10.029","article-title":"Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer","volume":"99","author":"Choi","year":"2012","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.bbagen.2023.130317_bb0115","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/mp2000428","article-title":"Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes","volume":"8","author":"Qhattal","year":"2011","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.bbagen.2023.130317_bb0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2011.06.031","article-title":"Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response","volume":"156","author":"Mizrahy","year":"2011","journal-title":"J. Controll. Rel."},{"key":"10.1016\/j.bbagen.2023.130317_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/02652048.2019.1692943","article-title":"Non-small cell lung cancer tumour antigen, MUC-1 peptide-loaded non-aggregated poly (lactide-co-glycolide) nanoparticles augmented cellular uptake in mouse professional antigen-presenting cells: optimisation and characterisation","volume":"37","author":"Jyoti","year":"2019","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.bbagen.2023.130317_bb0130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/02652048.2020.1823500","article-title":"Protamine sulphate coated poly (lactide-co-glycolide) nanoparticles of MUC-1 peptide improved cellular uptake and cytokine release in mouse antigen presenting cells","volume":"37","author":"Jyoti","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.bbagen.2023.130317_bb0135","series-title":"Scale-up, Preclinical and Clinical Status of Poly (Lactide-co-Glycolide) and its Copolymers Based Drug Delivery Systems in \u201cNanomaterials: Evolution and Advancement towards Therapeutic Drug Delivery (Part II)\u201d","first-page":"246","volume":"13","author":"Bajwa","year":"2021"},{"issue":"5","key":"10.1016\/j.bbagen.2023.130317_bb0140","first-page":"395","article-title":"Inhalable polymeric micro and nano-immunoadjuvants for developing therapeutic vaccines in the treatment of non-small cell lung cancer,Curr","volume":"28","author":"Dondulkar","year":"2022","journal-title":"Pharm Des"},{"issue":"3","key":"10.1016\/j.bbagen.2023.130317_bb0145","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","article-title":"PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution","volume":"9","author":"Hussain","year":"2019","journal-title":"Drug Del. Transl. Res."},{"issue":"7","key":"10.1016\/j.bbagen.2023.130317_bb0150","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1248\/bpb.b12-00029","article-title":"C, low molecular weight (1kDa) polyethylene glycol conjugation markedly enhances the hypoglycemic effects of intranasally administered exendin-4 in type 2 diabetic db\/db mice","volume":"35","author":"Kim","year":"2012","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.bbagen.2023.130317_bb0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1463-1326.2007.00823.x","article-title":"C, PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db\/db mice","volume":"10","author":"Youn","year":"2008","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.bbagen.2023.130317_bb0160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2023.130317_bb0165","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s10989-021-10303-y","article-title":"Armamentarium of cryoprotectants in peptide vaccines: mechanistic insight, challenges, opportunities and future prospects","volume":"27","author":"Dalvi","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.bbagen.2023.130317_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658895","article-title":"RNA-cholesterol nanoparticles function as potent immune activators via TLR7 and TLR8","volume":"12","author":"Obermann","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2023.130317_bb0175","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.vaccine.2010.11.010","article-title":"PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration","volume":"29","author":"Stano","year":"2011","journal-title":"Vaccine."},{"issue":"2","key":"10.1016\/j.bbagen.2023.130317_bb0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2007-03-079681","article-title":"Hematopoietic cytokines","volume":"111","author":"Metcalf","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2023.130317_bb0185","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0014-3057(83)90016-2","article-title":"Attachment of drugs to polyethylene glycols","volume":"19","author":"Zalipsky","year":"1983","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bbagen.2023.130317_bb0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/02652048.2016.1169324","article-title":"Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses","volume":"33","author":"Kaur","year":"2016","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.bbagen.2023.130317_bb0195","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijpharm.2014.07.038","article-title":"Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery","volume":"473","author":"Park","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.bbagen.2023.130317_bb0200","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/bc970183n","article-title":"Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses","volume":"9","author":"Guan","year":"1998","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.bbagen.2023.130317_bb0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0939-6411(00)00079-5","article-title":"Revisiting PLA\/PLGA microspheres: an analysis of their potential in parenteral vaccination","volume":"50","author":"Johansen","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2023.130317_bb0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.bbagen.2023.130317_bb0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1208\/s12248-009-9169-1","article-title":"Evaluation of mucoadhesive PLGA microparticles for nasal immunization","volume":"12","author":"Pawar","year":"2010","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.bbagen.2023.130317_bb0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/9780470942390.mo110201","article-title":"Performing bronchoalveolar lavage in the mouse","volume":"2","author":"Daubeuf","year":"2012","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.bbagen.2023.130317_bb0225","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.4049\/jimmunol.1203131","article-title":"Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints","volume":"191","author":"Hardy","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bbagen.2023.130317_bb0230","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.biomaterials.2010.11.010","article-title":"PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo","volume":"32","author":"Choi","year":"2011","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bbagen.2023.130317_bb0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","article-title":"How to study proteins by circular dichroism","volume":"1751","author":"Kelly","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2023.130317_bb0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/10731199.2012.696063","article-title":"Immune-stimulating potential of cell envelope proteins from vibrio cholerae associated to chitosan microparticles: an in vitro study","volume":"40","author":"Dev","year":"2012","journal-title":"Artif. Cells Blood Substit. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbagen.2023.130317_bb0245","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1039\/D1NR06512B","article-title":"Pulmonary delivery of mucosal nanovaccines","volume":"14","author":"Tang","year":"2022","journal-title":"Nanoscale"},{"issue":"5","key":"10.1016\/j.bbagen.2023.130317_bb0250","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1172\/JCI35548","article-title":"Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions","volume":"119","author":"Buono","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2023.130317_bb0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biomaterials.2016.03.039","article-title":"Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy","volume":"97","author":"Siefert","year":"2016","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.bbagen.2023.130317_bb0260","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.drudis.2016.12.009","article-title":"Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy","volume":"22","author":"Wickens","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbagen.2023.130317_bb0265","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/2326-6066.CIR-15-0099-T","article-title":"Simultaneous targeting of Fc\u03b3Rs and Fc\u03b1RI enhances tumor cell killing","volume":"3","author":"Brandsma","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbagen.2023.130317_bb0270","first-page":"439","article-title":"Immunologic approaches to the treatment of prostate cancer","volume":"26","author":"Harris","year":"1999","journal-title":"Semin. Oncol."},{"issue":"16","key":"10.1016\/j.bbagen.2023.130317_bb0275","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.2217\/nnm.13.225","article-title":"Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery","volume":"9","author":"Harde","year":"2014","journal-title":"Nanomedicine (London, England)"},{"issue":"57","key":"10.1016\/j.bbagen.2023.130317_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd8003","article-title":"Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells","volume":"6","author":"Rakhra","year":"2021","journal-title":"Sci. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416523000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416523000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:02:50Z","timestamp":1736348570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416523000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0304416523000156"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2023.130317","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronate decorated polyethylene glycol linked poly(lactide-co-glycolide) nanoparticles encapsulating MUC-1 peptide augmented mucosal immune response in Balb\/c mice through inhalation route","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2023.130317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"130317"}}